Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
针对 5-11 岁患有过敏症、哮喘和免疫缺陷的儿童,BNT162b2 mRNA COVID-19 疫苗的管理:意大利儿科过敏和免疫学会 (SIAIP) 的共识
期刊:Italian Journal of Pediatrics
影响因子:3.1
doi:10.1186/s13052-022-01272-z
Novembre, Elio; Tosca, Mariangela; Caffarelli, Carlo; Calvani, Mauro; Cardinale, Fabio; Castagnoli, Riccardo; Chiappini, Elena; Cravidi, Claudio; Del Giudice, Michele Miraglia; Duse, Marzia; Licari, Amelia; Manti, Sara; Martelli, Alberto; Ricci, Giampaolo; Pingitore, Giuseppe; Marseglia, Gian Luigi
AIP
Immunology/Inflammation
哮喘
免疫/内分泌